Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lipopeptide AB was a Swedish biotechnology company focused on the development of novel peptide-based therapeutics for the treatment of infections and inflammatory conditions. The company utilized a proprietary technology platform to design synthetic lipopeptides that mimic the body's natural antimicrobial defense mechanisms. Its lead candidates were aimed at addressing unmet needs in wound care and dermatology, specifically targeting bacterial pathogens while modulating the immune response. Despite promising early-stage research, the company is no longer active, and its intellectual property or assets may have been transitioned to other entities or academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lipopeptide.